SCHEMBL4445222

SCHEMBL4445222

COc1ccc(N(C(=O)OC(C)(C)C)C2CCCNC2)c(N)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPLP1 P05386 2/20 0.40
RPLP0 P05388 2/20 0.40
RPS17 P08708 2/20 0.40
RPSA P08865 2/20 0.40
RPS2 P15880 2/20 0.40
RPL35A P18077 2/20 0.40
RPL7 P18124 2/20 0.40
RPL17 P18621 2/20 0.40
RPS4Y1 P22090 2/20 0.40
RPS3 P23396 2/20 0.40
RPS12 P25398 2/20 0.40
RPL13 P26373 2/20 0.40
RPL10 P27635 2/20 0.40
RPL12 P30050 2/20 0.40
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 2/20 0.40
RPL22 P35268 2/20 0.40
RPL4 P36578 2/20 0.40
RPS19 P39019 2/20 0.40
RPL3 P39023 2/20 0.40
RPL13A P40429 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4443673 0.88 RPLP1 (0.34) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4439262 0.87 EPHX2 (0.39) MC4RHTR2CALDH1A1MEN1KMT2A
SCHEMBL4437552 0.87 SLC6A2 (0.39) KCNH2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL4433912 0.86 FLT3 (0.35) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4445379 0.84 RPLP1 (0.38) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4431999 0.84 MEN1 (0.34) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4438021 0.82 KCNH2 (0.37) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4434418 0.81 RPLP1 (0.34) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3410670 0.80 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4436048 0.80 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed